Association studies of WD repeat domain 3 and chitobiosyldiphosphodolichol beta-mannosyltransferase genes with schizophrenia in a Japanese population

PloS One
Momoko KobayashiToru Nishikawa

Abstract

Schizophrenia and schizophrenia-like symptoms induced by the dopamine agonists and N-methyl-D aspartate type glutamate receptor antagonists occur only after the adolescent period. Similarly, animal models of schizophrenia by these drugs are also induced after the critical period around postnatal week three. Based upon the development-dependent onsets of these psychotomimetic effects, by using a DNA microarray technique, we identified the WD repeat domain 3 (WDR3) and chitobiosyldiphosphodolichol beta-mannosyltransferase (ALG1) genes as novel candidates for schizophrenia-related molecules, whose mRNAs were up-regulated in the adult (postnatal week seven), but not in the infant (postnatal week one) rats by an indirect dopamine agonist, and phencyclidine, an antagonist of the NMDA receptor. WDR3 and other related proteins are the nuclear proteins presumably involved in various cellular activities, such as cell cycle progression, signal transduction, apoptosis, and gene regulation. ALG1 is presumed to be involved in the regulation of the protein N-glycosylation. To further elucidate the molecular pathophysiology of schizophrenia, we have evaluated the genetic association of WDR3 and ALG1 in schizophrenia. We examined 21 single nucl...Continue Reading

References

Jan 1, 1992·Neurotoxicology and Teratology·F M Scalzo, R R Holson
Mar 1, 1989·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·D L Reich, G Silvay
Jan 1, 1987·Psychopharmacology·Y FujiwaraS Otsuki
Feb 1, 1982·Anesthesiology·P F WhiteA J Trevor
Jul 11, 2000·Acta Psychiatrica Scandinavica. Supplementum·A Leung, P Chue
Apr 21, 2001·Biometrics·B Devlin, K Roeder
May 25, 2002·Science·Stacey B GabrielDavid Altshuler
Jun 13, 2003·American Journal of Human Genetics·Cathryn M LewisTomas Helgason
Dec 19, 2003·American Journal of Human Genetics·Christopher S CarlsonDeborah A Nickerson
Aug 7, 2004·Bioinformatics·J C BarrettM J Daly
Nov 4, 2004·Biological Psychiatry·Kazuo YamadaTakeo Yoshikawa
Sep 18, 2007·Nature Genetics·Barbara E StrangerEmmanouil T Dermitzakis
Feb 1, 2008·Nature·Kerstin S WendtJan-Michael Peters
May 9, 2008·PLoS Biology·Eric E SchadtRoger Ulrich
Mar 5, 2009·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Eiji HattoriTakeo Yoshikawa
Mar 31, 2009·Schizophrenia Bulletin·Angus W MacDonald, S Charles Schulz
Apr 8, 2009·Molecular Psychiatry·M Y M NgC M Lewis
Sep 1, 2009·Schizophrenia Research·Deborah BauerRobert E McCullumsmith
Sep 30, 2009·Molecular Psychiatry·A IngasonD M St Clair
May 21, 2010·Psychiatry Research·Byungsu KimKyuyoung Song
Sep 21, 2012·BMC Psychiatry·Lars ClemmensenHans-Christoph Steinhausen
Nov 30, 2012·Nucleic Acids Research·Jesse D ZiebarthYan Cui
Nov 19, 2014·Methods in Molecular Biology·Jason H Moore, Peter C Andrews
Jan 9, 2016·Neuroscience and Biobehavioral Reviews·Adrianna Mendrek, Adham Mancini-Marïe
Apr 15, 2017·The Journal of Experimental Medicine·Yuki FujitaToshihide Yamashita

❮ Previous
Next ❯

Methods Mentioned

BETA
glycosylation
genotyping
Assay

Software Mentioned

Haploview
GeneSpring GX
PLINK
MDR
SDS
MDRpt

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Related Papers

American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics
Xiangdong DengYasuyuki Fukumaki
© 2022 Meta ULC. All rights reserved